About Sight Sciences
Sight Sciences is a company based in Menlo Park (United States) founded in 2006. Sight Sciences has raised $128.59 million across 10 funding rounds from investors including Janus Henderson Investors, MidCap Financial and KCK MedTech. The company has 216 employees as of December 31, 2024. Sight Sciences operates in a competitive market with competitors including Alcon, Iantrek, Keranova, Orbit Biomedical and Migos Medical, among others.
- Headquarter Menlo Park, United States
- Employees 216 as on 31 Dec, 2024
- Stage Public
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
- Legal Name Sight Sciences, Inc.
-
Annual Revenue
$79.87 M (USD)-1.47as on Dec 31, 2024
-
Net Profit
-$51.51 M (USD)7.27as on Dec 31, 2024
-
EBITDA
-$49.82 M (USD)12.07as on Dec 31, 2024
-
Total Equity Funding
$128.59 M (USD)
in 10 rounds
-
Latest Funding Round
$23.25 M (USD), Series E
Dec 03, 2020
-
Investors
Janus Henderson Investors
& 5 more
-
Employee Count
216
as on Dec 31, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Sight Sciences
Sight Sciences is a publicly listed company on the NASDAQ with ticker symbol SGHT in USA, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
People of Sight Sciences
Unlock access to complete
Unlock access to complete
Sales and Marketing
52 people
Leadership Team
25 people
Software Development Team
11 people
Product Management Team
8 people
Senior Team
7 people
Finance and Accounting
6 people
Glaucoma Team
4 people
Legal and Compliance
3 people
Unlock access to complete
Funding Insights of Sight Sciences
Sight Sciences has successfully raised a total of $128.59M across 10 strategic funding rounds. The most recent funding activity was a Series E round of $23.25 million completed in December 2020. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Sight Sciences
Sight Sciences has secured backing from 6 investors, including venture fund investors. Prominent investors backing the company include Janus Henderson Investors, MidCap Financial and KCK MedTech.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Multiple sectors are targeted for venture capital investments.
|
Locked | Locked | Locked | |
|
Private debt funds are managed across multiple sectors.
|
Locked | Locked | Locked | |
|
-
|
Locked | Locked | Locked |
Investor details for Sight Sciences
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Sight Sciences
Investment portfolio details for Sight Sciences
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Sight Sciences
Detailed financials for Sight Sciences
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Sight Sciences Comparisons
Peer comparison for Sight Sciences
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Sight Sciences
Sight Sciences operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Alcon, Iantrek, Keranova, Orbit Biomedical and Migos Medical, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Developer of a wide range of eye care products
|
|
| Locked | Locked | Locked |
Developer of a minimally invasive eye surgery technology
|
|
| Locked | Locked | Locked |
Surgical equipment for anterior chamber ophthalmic surgery is developed.
|
|
| Locked | Locked | Locked |
Medical device for ophthalmic surgery is developed.
|
|
| Locked | Locked | Locked |
Minimally invasive ophthalmology devices for glaucoma are developed.
|
Detailed competitors of Sight Sciences
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Sight Sciences
Complete news archive for Sight Sciences
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Sight Sciences
Sight Sciences was founded in 2006 and raised its 1st funding round 5 years after it was founded.
Sight Sciences is headquartered in Menlo Park, United States. It is registered at Menlo Park, California, United States.
Sight Sciences is a funded company, having raised a total of $128.59M across 10 funding rounds to date.
As of Dec 31, 2024, the latest employee count at Sight Sciences is 216.
Annual revenue of Sight Sciences is $79.87M as on Dec 31, 2024.
Sight Sciences was established in 2006 in Menlo Park, United States, within the medical device sector focused on ophthalmology. Surgical instruments and systems are created for managing conditions like primary open-angle glaucoma, Meibomian Gland Dysfunction, dry eye, and blepharitis. These tools support canaloplasty procedures aimed at lowering intraocular pressure among adult patients, with operations centered on innovation in eye care technologies.
Yes, Sight Sciences is publicly traded on NASDAQ under the ticker symbol SGHT.
Sight Sciences has 6 investors. Key investors include Janus Henderson Investors, MidCap Financial, KCK MedTech, Allegro Investment Fund, and SHD Partners.
The ticker symbol of Sight Sciences is SGHT on NASDAQ.